Quantum-Si (NASDAQ:QSI) Given Buy Rating at HC Wainwright

Quantum-Si (NASDAQ:QSI)‘s stock had its “buy” rating reissued by stock analysts at HC Wainwright in a research note issued on Tuesday, Marketbeat.com reports. They presently have a $4.00 price objective on the stock. HC Wainwright’s price target points to a potential upside of 186.74% from the company’s previous close.

Several other research firms have also commented on QSI. Wall Street Zen upgraded shares of Quantum-Si from a “sell” rating to a “hold” rating in a research report on Saturday, September 12th. Alliance Global Partners restated a “buy” rating on shares of Quantum-Si in a research report on Friday, August 14th. Finally, Weiss Ratings upgraded shares of Quantum-Si from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, September 24th. Two research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $2.50.

Quantum-Si Price Performance

NASDAQ QSI opened at $1.40 on Tuesday. Quantum-Si has a 1 year low of $0.69 and a 1 year high of $3.10. The company has a market capitalization of $305.34 million, a PE ratio of -3.03 and a beta of 3.21. The company has a fifty day moving average of $0.81 and a two-hundred day moving average of $0.88.

Quantum-Si (NASDAQ:QSI) last announced its earnings results on Thursday, August 13th. The company reported ($0.11) EPS for the quarter, meeting analysts’ consensus estimates of ($0.11). The business had revenue of $0.34 million during the quarter, compared to analysts’ expectations of $0.30 million. Quantum-Si had a negative net margin of 6,138.26% and a negative return on equity of 47.12%. On average, research analysts expect that Quantum-Si will post -0.47 earnings per share for the current year.

Institutional Investors Weigh In On Quantum-Si

Institutional investors have recently modified their holdings of the stock. Renaissance Technologies LLC acquired a new stake in shares of Quantum-Si in the 1st quarter valued at about $91,000. WINTON GROUP Ltd acquired a new stake in Quantum-Si in the second quarter worth $67,000. Green Alpha Advisors LLC acquired a new stake in Quantum-Si in the second quarter worth $41,000. Corient Private Wealth LP acquired a new stake in Quantum-Si in the second quarter worth $34,000. Finally, Hollencrest Capital Management increased its position in Quantum-Si by 301.1% in the first quarter. Hollencrest Capital Management now owns 40,111 shares of the company’s stock worth $31,000 after buying an additional 30,111 shares during the period. Institutional investors and hedge funds own 39.90% of the company’s stock.

Quantum-Si Company Profile

Quantum-Si Incorporated (NASDAQ:QSI) is a life sciences technology company focused on advancing proteomics, the study of proteins and their functions. The company develops tools intended to make protein analysis more accessible, scalable and cost-effective for researchers, pharmaceutical companies, biotechnology firms and academic institutions.

Its primary offering is the Platinum platform, which combines a benchtop protein sequencing instrument with single-use consumables and software.